Safety analysis of fluoroquinolone drugs in elderly patients over 65 based on FAERS
Different FQs exhibit varying ADE profiles across cardiovascular, vascular and lymphatic, renal and urinary, psychiatric, musculoskeletal and connective tissue, and ocular systems. Patients with underlying systemic diseases should avoid FQs with higher ADE risks for their conditions. Personalized medication plans for elderly patients should also be strengthened.
Authors
- Chengliang Wang (ORCID: https://orcid.org/0000-0003-0877-1064)
- Lan Luo (ORCID: https://orcid.org/0009-0008-8204-7975)
- Li Chen (ORCID: https://orcid.org/0000-0002-9738-6645)
- Xiting Tang
- Yanwei Li (ORCID: https://orcid.org/0009-0008-3939-6360)
Institutions
- University of the Basque Country (ES)
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
- Tibet Autonomous Region People's Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1080/14740338.2024.2392862
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.45